Showing results (51-60 of 61) with videos related to

Sort By:
Pageof 7
PM & R : the Journal of Injury, Function, and Rehabilitation|April 30, 2021
Investigating whole-brain metabolite abnormalities in the chronic stages of moderate or severe traumatic brain injuryJoanne C Lin, Christina Mueller, Kelsey A Campbell, et al.
Annals of Neurology|April 21, 2023
White Matter Changes after Neurobehavioral Therapy for Functional SeizuresChristina Mueller, Adam M Goodman, Jane B Allendorfer, et al.
Molecular Biology of the Cell|June 19, 2009
Novel roles of hakai in cell proliferation and oncogenesisAngélica Figueroa, Hirokazu Kotani, Yoshinobu Toda, et al.
Journal of Labelled Compounds & Radiopharmaceuticals|December 16, 2020
Production of [<sup>89</sup> Zr]Oxinate<sub>4</sub> and cell radiolabeling for human useAdriana V F Massicano, Jennifer L Bartels, Charlotte D Jeffers, et al.
The Journal of Biological Chemistry|April 16, 2003
Essential role of the apolipoprotein E receptor-2 in sperm developmentOlav M Andersen, Ching-Hei Yeung, Henrik Vorum, et al.
Science Advances|July 12, 2023
An organoid-based CRISPR-Cas9 screen for regulators of intestinal epithelial maturation and cell fateStine L Hansen, Hjalte L Larsen, Laura M Pikkupeura, et al.
The Journal of Experimental Medicine|June 15, 2011
ATF6beta is a host cellular target of the Toxoplasma gondii virulence factor ROP18Masahiro Yamamoto, Ji Su Ma, Christina Mueller, et al.
Journal of Biomedical Informatics|January 6, 2019
Federated electronic health records research technology to support clinical trial protocol optimization: Evidence from EHR4CR and the InSite platformBrecht Claerhout, Dipak Kalra, Christina Mueller, et al.
Plos Pathogens|October 17, 2015
Fundamental Roles of the Golgi-Associated Toxoplasma Aspartyl Protease, ASP5, at the Host-Parasite InterfacePierre-Mehdi Hammoudi, Damien Jacot, Christina Mueller, et al.
Lung Cancer (Amsterdam, Netherlands)|October 9, 2024
A phase Ib study of the combination of naporafenib with rineterkib or trametinib in patients with advanced and metastatic KRAS- or BRAF-mutant non-small cell lung cancerDavid Planchard, Jürgen Wolf, Benjamin Solomon, et al.
Pageof 7